It may take another decade for Australia to develop a hybrid speciality of cardiometabolic medicine straddling endocrinology and cardiology, but the first steps should be made now, the president of the American Diabetes Association (ADA) has told local clinicians. Speaking as a guest on a limbic webinar to discuss the highlights of the recent ADA ...
ADA president gives Australia a roadmap for cardiometabolic subspecialty
By Michael Woodhead
16 Jul 2020